TY - JOUR T1 - Prevalence of Mild Cognitive Impairment in the Lothian Birth Cohort 1936 JF - medRxiv DO - 10.1101/2020.10.08.20209130 SP - 2020.10.08.20209130 AU - Miles Welstead AU - Michelle Luciano AU - Graciela Muniz-Terrera AU - Adele M. Taylor AU - Tom C. Russ Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/12/2020.10.08.20209130.abstract N2 - Background The Lothian Birth Cohort 1936 (LBC1936) is a highly-phenotyped longitudinal study of cognitive and brain ageing. Given its substantial clinical importance, we derived an indicator of mild cognitive impairment (MCI) as well as amnestic and non-amnestic subtypes at three time points.Methods MCI status was derived at three waves of the LBC1936 at ages 76 (n=567), 79 (n=441), and 82 years (n=341). A general MCI category was derived as well as amnestic MCI (aMCI) and non-amnestic MCI (naMCI). A comparison was made between MCI derivations using normative data from the LBC1936 cohort versus the general UK population.Results MCI rates showed a proportional increase at each wave between 76 and 82 years from 15% to 18%. Rates of MCI subtypes also showed a proportional increase over time: aMCI 4% to 6%; naMCI 12% to 16%. Higher rates of MCI were found when using the LBC1936 normative data to derive MCI classification rather than UK-wide norms.Conclusions We found that MCI and aMCI rates in the LBC1936 were consistent with previous research. However, naMCI rates were higher than expected. Future LBC1936 research should assess the predictive factors associated with MCI prevalence to validate previous findings and identify novel risk factors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLBC1936 data collection and PhD scholarship is funded by the Disconnected Mind project funded by Age UK [MR/M01311/1] and MRC [G1001245/96099]. No payment or services were provided by third partiesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical permission for the LBC1936 study protocol was obtained from the Multi-Centre Research Ethics Committee for Scotland (Wave 1: MREC/01/0/56), the Lothian Research Ethics Committee (Wave 1: LREC/2003/2/29), and the Scotland A Research Ethics Committee (Waves 2, 3, 4 & 5: 07/MRE00/58).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesR script can be provided upon request ER -